2021

1. Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy-induced myelosuppression in patients with small cell lung cancer: Pooled analysis of three randomized phase 2 trials

   Cancer Medicine, Vol. 10, Núm. 17, pp. 5748-5756